The combination treatment regimen of ruxolitinib with low-dose mercaptopurine or cytarabine in frail patients with blast-phase myelofibrosis

Research output: Contribution to journal › Letter › peer-review

Department of Hospital Therapy

Overview
Cite this

DOI

https://doi.org/10.1111/bjh.14162
Final published version

Mikhail Fominykh
Vasily Shuvaev
Irina Martynkevich
Lyubov Polushkina
Vera Udaleva
Kudrat Abdulkadyrov

Original language	English
Pages (from-to)	645-646
Number of pages	2
Journal	British Journal of Haematology
Volume	178
Issue number	4
DOIs	https://doi.org/10.1111/bjh.14162
State	Published - 1 Aug 2017

Research areas

blast phase, combination treatment regimen, myelofibrosis, Ruxolitinib

Scopus subject areas

Hematology

ID: 46137683

SPbU Researchers Portal

Pure is an Elsevier product
This information resource may contain archival materials mentioning individuals
or legal entities included in the register of foreign agents by the Ministry of Justice
of the Russian Federation.
Log in to Pure